Madara Ratnadiwakara
Madara Ratnadiwakara
Postdoctoral Scientist, Hudson Institute of Medical Research
Verified email at
TitleCited byYear
Splicing factors as regulators of miRNA biogenesis–links to human disease
M Ratnadiwakara, M Mohenska, ML Änkö
Seminars in cell & developmental biology 79, 113-122, 2018
SRSF3 promotes pluripotency through Nanog mRNA export and coordination of the pluripotency gene expression program
M Ratnadiwakara, SK Archer, CI Dent, IR De Los Mozos, TH Beilharz, ...
Elife 7, e37419, 2018
Abstract A117: Vitamin D, parathyroid hormone, Cyp2r1, and breast cancer susceptibility in mice
M Ratnadiwakara, RB Williams, AC Blackburn
Molecular Cancer Research 11 (10 Supplement), A117-A117, 2013
The SuprMam1 breast cancer susceptibility locus disrupts the vitamin D/calcium/parathyroid hormone pathway and alters bone structure in congenic mice
M Ratnadiwakara, M Rooke, SJ Ohms, HJ French, RBH Williams, RW Li, ...
The Journal of steroid biochemistry and molecular biology 188, 48-58, 2019
SRSF3 confers selective processing of miR-17-92 cluster to promote tumorigenic properties in colorectal cancer
M Ratnadiwakara, R Engel, T Jarde, PJ McMurrick, HE Abud, ML Anko
bioRxiv, 667295, 2019
mRNA Stability Assay Using Transcription Inhibition by Actinomycin D in Mouse Pluripotent Stem Cells
X Du, HC Wu
eLIFE, 2018
RNA Immunoprecipitation Assay to Determine the Specificity of SRSF3 Binding to Nanog mRNA
AK Tripathi
eLIFE, 2018
Splicing factors as regulators of miRNA biogenesis–links to human
M Ratnadiwakara, M Mohenska, ML Änkö
Identification of pathways involved in breast cancer susceptibility-contribution of SuprMam loci
M Ratnadiwakara
The Australian National University, 2015
Contribution of genetic variation within SuprMam1 and SuprMam2 to breast cancer susceptibility
M Ratnadiwakara, M Rooke, R Williams, AC Blackburn
Hereditary cancer in clinical practice 10 (2), A90, 2012
The system can't perform the operation now. Try again later.
Articles 1–10